BIDOLLARI, ERIS
 Distribuzione geografica
Continente #
NA - Nord America 571
EU - Europa 205
AS - Asia 134
SA - Sud America 9
AF - Africa 7
OC - Oceania 1
Totale 927
Nazione #
US - Stati Uniti d'America 567
IT - Italia 65
SG - Singapore 51
CN - Cina 43
DE - Germania 36
IN - India 31
FI - Finlandia 28
SE - Svezia 26
UA - Ucraina 10
AR - Argentina 8
GB - Regno Unito 8
TG - Togo 7
CH - Svizzera 6
ID - Indonesia 6
IE - Irlanda 5
RO - Romania 5
CA - Canada 4
BG - Bulgaria 3
PL - Polonia 3
RU - Federazione Russa 3
ES - Italia 2
FR - Francia 2
KR - Corea 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
NL - Olanda 1
VN - Vietnam 1
Totale 927
Città #
Fairfield 82
Chandler 65
Ashburn 44
Beijing 40
Rome 38
Santa Clara 38
Wilmington 37
Singapore 35
Woodbridge 35
Cambridge 29
Princeton 23
Houston 22
Bremen 20
Seattle 18
Ann Arbor 17
Boston 17
Plano 16
Helsinki 15
Federal 8
Lawrence 7
Lomé 7
Cagliari 6
Falkenstein 6
Glasgow 6
Jakarta 6
San Paolo di Civitate 6
Andover 5
Dublin 5
Falls Church 5
Norwalk 5
San Diego 5
Bern 4
Millbury 4
Bühl 3
Milan 3
Moscow 3
Sofia 3
Toronto 3
Trento 3
Warsaw 3
Boardman 2
Buffalo 2
Castel di Sangro 2
Elche 2
Fairborn 2
Frick 2
Laurel 2
Sandston 2
Anápolis 1
Dearborn 1
Frankfurt am Main 1
Gunzenhausen 1
Hanoi 1
Hefei 1
Indiana 1
Jacksonville 1
Kunming 1
Las Vegas 1
Limbiate 1
London 1
Los Angeles 1
Mentana 1
Nanjing 1
Napoli 1
Ottawa 1
Paris 1
Phoenix 1
Qendra 1
Suceava 1
Trumbull 1
Vienna 1
Totale 736
Nome #
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 96
Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticles 80
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage juvenile onset huntington's disease 68
Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure? 64
Neural stem cells differentiated from human induced pluripotent stem cells (iPSCs) as a novel in vitro model to study developmental pathways in Huntington Disease 64
Cytotoxic effect induced by combination of polyamines metabolites and endocannabinoid, anandamide, on human cancer cells: a new anticancer strategy” 63
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of dentato-rubral-pallidoluysian atrophy (DRPLA) 61
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile huntington disease 61
Parkin mutation affects clock gene-dependent energy metabolism 59
Bovine serum amine oxidase and spermine in association with anandamide cause cytotoxicity in melanoma and colon adenocarcinoma cells 43
A new chemical compound (EHW 437) enhances the cytotoxic effect of spermine metabolites on human cancer cells 38
Chloroquine sensitizes human melanoma cells (M14) to the enzymatic oxidation products of spermine 36
Bovine Serim Amine Oxidase immobilized on polymers as new approach in anticancer therapy 35
Chemosensitizer Agents Associated with Polyamine enzymatic oxidation products Enhance apoptosis on MDR human tumour cells. A new approach in cancer therapy” 34
CHLOROQUINE POTENTIATES THE CYTOTOXIC EFFECT INDUCED BY ENZYMATIC OXIDATION PRODUCTS OF SPERMINE ON HUMAN COLON ADENOCARCINOMA LoVo CELLS: A NEW THERAPEUTIC APPROACH 34
CYTOTOXICITY INDUCED ON HUMAN MELANOMA CELLS (M14) BY ENZYMATIC OXIDATION PRODUCTS OF SPERMINE IS POTENTIATED BY CHLOROQUINE, A LYSOSOMOTROPIC COMPOUNDS. 30
The combined treatment with chloroquine and BSAO/spermine overcomes multidrug resistance of colon adenocarcinoma cells (LoVo): a new therapeutic approach 29
Spermine enzymatic oxidation products in cancer therapy: Lysosomotropic compounds and docetaxel potentiate their cytotoxicity 29
Spermine enzymatic oxidation products alone and in association with anandamide induce cytotoxicity in human cancer cells 29
Lysosomotropic compounds and Docetaxel sensitize cancer cells to enzymatic spermine metabolites. A new approach in tumour therapy 28
Totale 981
Categoria #
all - tutte 3.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020147 0 0 0 0 0 0 28 32 24 32 29 2
2020/202194 13 4 0 27 4 0 15 13 5 10 3 0
2021/2022184 3 13 11 6 32 7 2 16 16 18 21 39
2022/2023204 49 33 14 26 20 12 1 16 16 7 7 3
2023/2024105 11 15 0 8 8 9 0 10 0 15 13 16
2024/2025100 2 4 4 13 45 32 0 0 0 0 0 0
Totale 981